Aurion Biotech CEO Greg Kunst Named Ernst & Young 2024 Entrepreneur of the Year Mountain West Region
2024年6月18日 - 2:09AM
ビジネスワイヤ(英語)
Selected from 39 Finalists in the Mountain West
Region
Aurion Biotech, whose mission is to restore vision to millions
of patients with life-changing regenerative therapies, today
announced that CEO Greg Kunst has been named winner of the Ernst
& Young 2024 Entrepreneur of the Year award for the Mountain
West Region.
This press release features multimedia. View
the full release here:
https://www.businesswire.com/news/home/20240617202244/en/
The Mountain West program celebrates entrepreneurs from Alaska,
Colorado, Idaho, Montana, Oregon, Utah, Washington and Wyoming. Now
in its 38th year, Entrepreneur Of The Year is the pre-eminent
competitive business award for audacious leaders who disrupt
markets, revolutionize industries and have a transformational
impact on lives. Over the past four decades, the program has
recognized daring entrepreneurs with big ideas and bold actions
that reshape our world.
“On behalf of our patients, our physicians and our employees,
I’m delighted to accept this award,” said Greg Kunst, CEO of Aurion
Biotech. “Aurion Biotech is on a mission to bring our
transformational cell therapy to millions of patients who are at
risk of blindness resulting from corneal endothelial dystrophies.
Gaining this recognition from Ernst & Young is another
important step for us in our journey. I thank the panelists and
Ernst & Young staff who sponsor this award.”
Greg Kunst was part of a group of 39 entrepreneurs selected as
finalists by an independent panel of judges. The finalist
candidates were evaluated based on their demonstration of building
long-term value through entrepreneurial spirit, purpose, growth and
impact, among other core contributions and attributes.
“The 2024 Entrepreneur Of The Year Mountain West Award winners
are exceptional business leaders fueling innovation within their
industries and growth within their companies,” said Shawn Goff,
Partner and Entrepreneur Of The Year Mountain West Program
Co-Director. "These entrepreneurs are shining examples of how to
lead a scaling business and also care for their employees,
customers and communities.”
Entrepreneur Of The Year honors many different types of business
leaders for their ingenuity, courage and entrepreneurial spirit.
The program celebrates original founders who bootstrapped their
business from inception or who raised outside capital to grow their
company; transformational CEOs who infused innovation into an
existing organization to catapult its trajectory; and
multigenerational family business leaders who reimagined a legacy
business model to fortify it for the future.
About Aurion Biotech
Aurion Biotech is a clinical-stage biotech company, whose
mission is to restore vision to millions of patients with
life-changing regenerative therapies. It received the prestigious
Prix Galien award for best start-up in biotech. Its first candidate
is for the treatment of corneal edema secondary to corneal
endothelial disease, and the first clinically validated cell
therapy for corneal care, having received regulatory approval in
Japan. The Company has initiated clinical trials in the U.S. and
Canada. Privately held, Aurion Biotech is backed by Deerfield,
Alcon, Petrichor, Flying L Partners, Falcon Vision / KKR, and
Visionary Ventures. To learn more, visit www.aurionbiotech.com
View source
version on businesswire.com: https://www.businesswire.com/news/home/20240617202244/en/
Judith McGarry (corporate communications) 415-971-2900
judith.mcgarry@aurionbiotech.com
Beth Keshishian (biotech & business media) 917-912-7195
beth@bethkeshishian.com
Michele Gray (ophthalmology media) 917-449-9250
michele@mgraycommunications.com